Production (Stage)
Channel Therapeutics Corporation
CHRO
$1.22
-$0.0065-0.53%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 131.30K | 513.40K | 1.25M | 2.41M | 3.77M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.30K | 65.30K | 94.60K | 158.10K | 220.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 763.50K | 790.40K | 790.40K | 40.40K | 40.40K |
| Total Current Assets | 911.20K | 1.37M | 2.14M | 2.60M | 4.03M |
|
|
|||||
| Total Current Assets | 911.20K | 1.37M | 2.14M | 2.60M | 4.03M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 911.20K | 1.37M | 2.14M | 2.60M | 4.03M |
|
|
|||||
| Total Accounts Payable | 2.60M | 1.90M | 1.28M | 835.40K | 2.41M |
| Total Accrued Expenses | -- | -- | 300.00 | 363.40K | 493.90K |
| Short-term Debt | 2.50M | 2.19M | 2.29M | 1.59M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.11M | 4.08M | 3.57M | 2.79M | 2.90M |
|
|
|||||
| Total Current Liabilities | 5.11M | 4.08M | 3.57M | 2.79M | 2.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.50M | 2.19M | 2.29M | 1.59M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.11M | 4.08M | 3.57M | 2.79M | 2.90M |
|
|
|||||
| Common Stock & APIC | 19.25M | 18.76M | 18.12M | 17.67M | 17.21M |
| Retained Earnings | -23.44M | -21.48M | -19.55M | -17.85M | -16.08M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.20M | -2.71M | -1.43M | -182.50K | 1.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.20M | -2.71M | -1.43M | -182.50K | 1.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.20M | -2.71M | -1.43M | -182.50K | 1.13M |
|
|
|||||